BIRC5 and systemic sclerosis: The aim of the present study is to investigate the mechanism of WYHZTL formula against fibrosis in SSc regarding its effect on the expression and regulation of cyclin D1 and survivin in primary cultured human fibroblasts treated by the animal-mediated sera.